Re: Promissory Note

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

RVXoldtimer

Rank: President [?]

Points: 3190 [?]

Votes: 23 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Promissory Note

in response to

Re: Promissory Note

Telepanel

posted on Mar 10, 2021 01:17PM

That's all of the info. there is on SEDAR.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply